Gastric cancer surgery and tumor board performance study
Part of Cancer, Digestive system clinical trials.
This study looks at how tumor board discussions affect outcomes for people having surgery to cure gastric cancer. If you have gastric adenocarcinoma and are scheduled for curative surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gastric adenocarcinoma (a type of stomach cancer).
- You are 18 years old or older.
- You are a candidate for surgery that aims to remove all cancer.
- You have not had a previous less-invasive procedure like endoscopic removal.
- You are not pregnant.
- You did not need emergency surgery for a blocked, bleeding, or torn stomach.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how medicines given around the time of stomach cancer surgery may change the “tumor microenvironment,” which is the biology around the tumor. It may help doctors better understand which perioperative treatments work best for locally advanced, operable stomach cancer.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
This trial is testing a combined approach using two types of endoscopy (a tube with a camera) along with minimally invasive surgery to treat early-stage stomach cancer. The goal is to remove the cancer with less impact on your body compared to standard surgery.
This trial is looking at whether giving extra treatment after surgery for stomach cancer can help lower the chance of it coming back. It is for people who had a specific kind of chemotherapy and immunotherapy before surgery and then had their stomach removed.
Hear when a new Stomach Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.